Reference health

Icaritin promotes tumor T‐cell infiltration and induces antitumor immunity in mice

https://doi.org/10.1002/eji.201948225

28/28 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 28 checked references that resolve

resolves10.1016/j.neuroscience.2006.12.059

Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway

resolves10.1142/S0192415X15500627

Icaritin Attenuates Myocardial Ischemia and Reperfusion Injury Via Anti-Inflammatory and Anti-Oxidative Stress Effects in Rats

resolves10.1016/j.biomaterials.2015.04.038

Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: Proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits

resolves10.1371/journal.pone.0041264

Icaritin, an Exogenous Phytomolecule, Enhances Osteogenesis but Not Angiogenesis—An In Vitro Efficacy Study

resolves10.1007/s13277-015-4134-3

Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells

resolves10.1038/nri3175

Coordinated regulation of myeloid cells by tumours

resolves10.1038/nrc3581

History of myeloid-derived suppressor cells

resolves10.1200/JCO.2010.30.5037

Tumor-Infiltrating CD8<sup>+</sup>Lymphocytes Predict Clinical Outcome in Breast Cancer

resolves10.1158/0008-5472.CAN-13-0371

Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

resolves10.1038/nrc3239

The blockade of immune checkpoints in cancer immunotherapy

resolves10.1056/NEJMoa1200690

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

resolves10.1016/j.it.2015.02.006

Immune-mediated mechanisms influencing the efficacy of anticancer therapies

resolves10.1038/nrc.2016.54

The role of myeloid cells in cancer therapies

resolves10.1016/j.canlet.2008.03.012

Myeloid-derived suppressor cell role in tumor-related inflammation

resolves10.1053/j.gastro.2008.03.020

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells

resolves10.1084/jem.20082173

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1

resolves10.1158/0008-5472.CAN-12-4115

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

resolves10.1158/0008-5472.CAN-09-1882

Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer

resolves10.1172/JCI60083

STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients

resolves10.1016/j.immuni.2013.01.004

Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy

resolves10.4049/jimmunol.1490019

IL-2: The First Effective Immunotherapy for Human Cancer

resolves10.1056/NEJMoa1200694

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

resolves10.1158/0008-5472.CAN-08-3529

Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF

resolves10.1158/0008-5472.CAN-09-2587

Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine

resolves10.1038/nm863

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

resolves10.1038/nmat4822

Designer vaccine nanodiscs for personalized cancer immunotherapy

resolves10.1038/nature13954

PD-1 blockade induces responses by inhibiting adaptive immune resistance

resolves10.1002/eji.201646632

Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>

What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1002/eji.201948225"><img src="https://citestamp.com/citestamped/10.1002/eji.201948225/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>

[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1002/eji.201948225/badge.svg)](https://citestamp.com/citestamped/10.1002/eji.201948225)